News from Vivetus®
40% Drug Rise in Trial: Berberine Interactions ...
A two week trial found berberine raised a CYP3A4 marker about 40% and reduced CYP2D6. See which medicines are risky and what monitoring helps.
40% Drug Rise in Trial: Berberine Interactions ...
A two week trial found berberine raised a CYP3A4 marker about 40% and reduced CYP2D6. See which medicines are risky and what monitoring helps.
Monitor These Labs on Long Term Berberine for H...
Evidence first guide for health minded adults on long term berberine: six month trial limits, key interaction risks, dosing notes, and which labs to monitor.
Monitor These Labs on Long Term Berberine for H...
Evidence first guide for health minded adults on long term berberine: six month trial limits, key interaction risks, dosing notes, and which labs to monitor.
47% Cortisol Drop in Cells, Not Humans: Vivetus...
Cell and animal studies show apigenin can cut cortisol in vitro by 47%, but human trials are missing. Read Vivetus' evidence first take and shopping notes.
47% Cortisol Drop in Cells, Not Humans: Vivetus...
Cell and animal studies show apigenin can cut cortisol in vitro by 47%, but human trials are missing. Read Vivetus' evidence first take and shopping notes.
NMN and fertility: in vitro oocyte rescue rose ...
Animal studies show NMN improves oocyte markers, but human evidence is limited to tolerability trials and one lab signal. Read dosing, risks, and...
NMN and fertility: in vitro oocyte rescue rose ...
Animal studies show NMN improves oocyte markers, but human evidence is limited to tolerability trials and one lab signal. Read dosing, risks, and...
2026 Meta Analysis: NMN vs NR Shows No Consiste...
An evidence-first review of NMN and NR. A 2025 meta-analysis found no consistent functional gains despite blood NAD+ rises; Vivetus adds a 12-week...
2026 Meta Analysis: NMN vs NR Shows No Consiste...
An evidence-first review of NMN and NR. A 2025 meta-analysis found no consistent functional gains despite blood NAD+ rises; Vivetus adds a 12-week...
Apigenin and Sleep: Chamomile Data, Not Proof f...
Chamomile trials (34 adults, 28 days) offer limited support for apigenin and sleep. An evidence-forward guide on risks, product checks and how to trial...
Apigenin and Sleep: Chamomile Data, Not Proof f...
Chamomile trials (34 adults, 28 days) offer limited support for apigenin and sleep. An evidence-forward guide on risks, product checks and how to trial...